According to the results of a prognosis analysis based on IHC staining (Figure 2(a)), MsrB1 was positively expressed in 84/135 patients, and high MsrB1 expression was correlated with poor prognoses with respect to overall survival and tumor-free survival (P < 0.05; Figures 2(b) and 2(c), resp). The gene discussed is MSRB1; the disease is neoplasm.